人工授精の市場規模・シェア・成長分析 (種類別、供給源の種類別、最終用途別、地域別)：産業予測 (2024～2031年)

世界の人工授精の市場規模は、2022年に21億米ドルと評価され、2023年の22億米ドルから2031年には38億米ドルに拡大し、予測期間 (2024～2031年) に8.01%のCAGRで成長する見通しです。

生殖補助医療技術の市場は、不妊率の上昇と人工授精技術に対する需要の増加によって大きな成長を遂げています。この急成長は、ライフスタイルの変化や、子宮内膜症や多嚢胞性卵巣症候群 (PCOS) などの病状の蔓延によるところが大きく、高度な生殖ソリューションが必要とされています。さらに、新興国における人工授精の受け入れ拡大も市場拡大を後押ししています。精子や卵子の選別方法の改善、凍結保存技術、着床前遺伝学的検査などの技術的進歩も成長を後押ししています。さらに、同性婚の合法化やLGBTQ+の親になることの幅広い受け入れといった社会的変化や、ドナー精子・卵子の利用可能性も、業界を前進させています。不妊に関する政策、認知度の向上、教育的取り組みが、個別化された治療オプションに対する需要の高まりとともに、この成長軌道に寄与しています。その他、生殖医療に対する保険適用範囲の拡大、職業志向による出産遅延の傾向、人工授精サービスを提供するクリニックや医療機関の急増なども、市場ダイナミクスを高める要因となっています。これらの要素を総合すると、生殖補助医療を求める多様な人々にとって、より包括的で利用しやすいものとなりつつある、強固で進化した市場環境がうかがえます。

目次

イントロダクション

• 分析目的
• 定義
• 市場範囲

分析手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場の概要と見通し
• 需給動向の分析
• セグメント別の機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 技術の進歩
• 規制情勢
• 特許分析
• バリューチェーン分析
• PESTEL分析
• マクロ経済指標
• 貿易分析

世界の人工授精の市場規模 (種類別)・CAGR (2024～2031年)

• 子宮内授精
• 子宮頸管内授精
• 膣内授精
• 卵管内授精

世界の人工授精の市場規模 (供給源の種類別)・CAGR (2024～2031年)

• 配偶者間人工授精 (AIH)
• 非配偶者間人工授精 (AID)

世界の人工授精の市場規模 (エンドユーザー別)・CAGR (2024～2031年)

• 不妊治療クリニック・その他の施設
• 在宅

世界の人工授精の市場規模 (地域別)・CAGR (2024～2031年)

• 北米 (種類別、供給源別、エンドユーザー別)
  • 米国
  • カナダ
• 欧州 (種類別、供給源別、エンドユーザー別)
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州
• アジア太平洋 (種類別、供給源別、エンドユーザー別)
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ (種類別、供給源別、エンドユーザー別)
  • ブラジル
  • その他ラテンアメリカ
• 中東・アフリカ (種類別、供給源別、エンドユーザー別)
  • 湾岸協力会議 (GCC) 諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング (2023年)
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析 (2023年)
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の対前年成長率 (YoY) の比較 (2021～2023年)

主要企業プロファイル

• Genea Pty Limited
• Vitrolife
• Rinovum Women's Health, LLC
• Pride Angel
• HI-TECH SOLUTIONS
• FUJIFILM Irvine Scientific
• Kitazato Corporation
• Rocket Medical plc
• Conceivex, Inc.
• Genea Limited
• Genus plc.
• Zoetis Inc.
• ABS Global
• Hamilton Thorne Inc.
• Continental Genetics
• Select Series
• Neogen Corporations
• Agtech inc
• Imv Technologies
• TenderNeeds Fertility LLC

結論と推奨事項

Global Artificial Insemination Market size was valued at USD 2.1 billion in 2022 and is poised to grow from USD 2.2 billion in 2023 to USD 3.8 billion by 2031, growing at a CAGR of 8.01% during the forecast period (2024-2031).

The market for assisted reproductive technologies is experiencing significant growth, driven by a rise in infertility rates and an increasing demand for artificial insemination techniques. This surge is largely attributed to lifestyle changes and the prevalence of medical conditions such as endometriosis and polycystic ovary syndrome (PCOS), necessitating advanced reproductive solutions. Additionally, the growing acceptance of artificial insemination in developing countries further supports market expansion. Technological advancements like improved sperm and egg selection methods, cryopreservation techniques, and pre-implantation genetic testing are also fueling growth. Furthermore, societal changes, including the legalization of same-sex marriage and broader acceptance of LGBTQ+ parenthood, alongside the availability of donor sperm and eggs, are propelling the industry forward. Enabling policies, increased awareness, and educational initiatives regarding artificial insemination and infertility are contributing to this growth trajectory, along with a heightened demand for personalized treatment options. Other factors enhancing market dynamics include expanding insurance coverage for reproductive procedures, a trend toward delayed childbearing favoring professional aspirations, and the proliferation of clinics and medical institutions offering artificial insemination services. Collectively, these elements indicate a robust and evolving market landscape that is becoming more inclusive and accessible to a diverse range of individuals seeking reproductive assistance.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Insemination market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Insemination Market Segmental Analysis

The Global Artificial Insemination Market is segmented into Type, Source Type, End Use, and Region. Based on Type, the market is segmented into Intrauterine, Intracervical, Intravaginal, and Intratubal. Based on Source Type, the market is segmented into AIH-Husband and AID-Donor. Based on End Use, it is segmented into Fertility Clinics & Other Facilities, and Home. Based on Region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Driver of the Global Artificial Insemination Market

The rising infertility rates globally serve as a significant market driver for the Global Artificial Insemination market. As couples and individuals struggle with delayed conception due to changing lifestyles, environmental factors, and an increase in reproductive health disorders, the demand for assisted reproductive technologies has surged. Artificial insemination emerges as a vital solution for those unable to conceive naturally, fostering greater acceptance and awareness of fertility treatments. Furthermore, an increasing societal interest in advanced reproductive methods strengthens the market's growth potential, as more individuals actively seek out artificial insemination to achieve their reproductive aspirations. This trend solidifies its status as a necessity in modern reproductive healthcare.

Restraints in the Global Artificial Insemination Market

The global artificial insemination market faces significant restraint due to the high costs associated with treatment, which often surpasses the financial capacity of many individuals and couples, particularly in lower-income demographics. The expenses associated with multiple treatment cycles, medications, and supplementary medical procedures can be prohibitive, especially in regions with inadequate insurance coverage for infertility treatments. This financial barrier limits access to artificial insemination, creating disparities in reproductive healthcare access. To address this issue and broaden the market's reach, it is essential to implement strategies aimed at reducing costs and enhancing affordability, thus making these services accessible to a wider population.

Market Trends of the Global Artificial Insemination Market

The Global Artificial Insemination market is witnessing a significant trend driven by the increasing utilization of advanced reproductive technologies. Innovations in genetic screening, cryopreservation, and high-tech sperm processing techniques have enhanced conception rates while minimizing invasiveness. Notable advancements include preimplantation genetic testing, which screens embryos for genetic disorders, thereby offering couples greater confidence in their reproductive choices. Additionally, improvements in sperm freezing and thawing methods provide patients with more flexible options. This technological evolution aims to personalize treatment protocols and boost success rates, ultimately broadening the market's growth and meeting the rising demand for effective reproductive solutions worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Trade Analysis

Global Artificial Insemination Market Size by Type & CAGR (2024-2031)

• Intrauterine Insemination
• Intracervical Insemination
• Intravaginal Insemination
• Intratubal Insemination

Global Artificial Insemination Market Size by Source Type & CAGR (2024-2031)

• AIH-Husband
• AID-Donor

Global Artificial Insemination Market Size by End User & CAGR (2024-2031)

• Fertility clinics & other facilities
• Home

Global Artificial Insemination Market Size by Region & CAGR (2024-2031)

• North America, (Type, Source, End User)
  • US
  • Canada
• Europe, (Type, Source, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Type, Source, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Type, Source, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Type, Source, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Genea Pty Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rinovum Women's Health, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pride Angel
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HI-TECH SOLUTIONS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Irvine Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kitazato Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rocket Medical plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Conceivex, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genus plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABS Global
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Thorne Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Continental Genetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Select Series
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporations
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agtech inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imv Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TenderNeeds Fertility LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation